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Abstract
Background: In regenerative medicine the maintenance of stem cell properties is of crucial importance. Ageing is
considered a cause of reduced stemness capability. The limbus is a stem niche of easy access and harbors two
stem cell populations: epithelial stem cells and fibroblast-like stem cells. Our aim was to investigate whether donor
age and/or long-term culture have any influence on stem cell marker expression and the profiles in the fibroblast-like
stem cell population.
Methods: Fibroblast-like stem cells were isolated and digested from 25 limbus samples of normal human corneo-scleral
rings and long-term cultures were obtained. SSEA4 expression and sphere-forming capability were evaluated;
cytofluorimetric assay was performed to detect the immunophenotypes HLA-DR, CD45, and CD34 and the
principle stem cell markers ABCG2, OCT3/4, and NANOG. Molecular expression of the principal mesenchymal
stem cell genes was investigated by real-time PCR. Two-dimensional gel electrophoresis and mass spectrometric
sequencing were performed and a stable proteomic profile was identified. The proteins detected were explored
by gene ontology and STRING analysis. The data were reported as means ± SD, compared by Student’s unpaired
t test and considering p < 0.05 as statistically significant.
Results: The isolated cells did not display any hematopoietic surface marker (CD34 and CD45) and HLA-DR and
they maintained these features in long-term culture. The expression of the stemness genes and the multilineage
differentiation under in-vitro culture conditions proved to be well maintained. Proteomic analysis revealed a
fibroblast-like stem cell profile of 164 proteins with higher expression levels. Eighty of these showed stable
expression levels and were involved in maintenance of “the stem gene profile”; 84 were differentially expressed and
were involved in structural activity.
Conclusions: The fibroblast-like limbal stem cells confirmed that they are a robust source of adult stem cells and that
they have good plasticity, good proliferative capability, and long-term maintenance of stem cell properties, independently
of donor age and long-term culture conditions. Our findings confirm that limbal fibroblast-like stem cells are
highly promising for application in regenerative medicine and that in-vitro culture steps do not influence their
stem cell properties. Moreover, the proteomic data enrich our knowledge of fibroblast-like stem cells.
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Background
The limbus, located at the junction of the cornea and
conjunctiva of the ocular surface, is characterized by
stromal invaginations (the palisades of Vogt). These
structures give anatomical and functional properties pro-
tecting stem cells from insults and allowing constant
renewal of the corneal epithelium [1–8].
Two stem cell populations have been described in the
limbus: limbal epithelial stem cells (LESCs) and limbal
stromal stem cells. Their similar and different features
have not been defined unequivocally [9–12]. Polisetty
et al. [13] proposed a role for limbal mesenchymal stromal
cells (MSCs) in maintaining support of the stem cell niche.
More recent data have validated the hypothesis of “niche
stromal cells” based on the capacity of limbal stromal cells
to be an efficient feeder layer for ex-vivo limbal epithelial
cell expansion [8, 14, 15]. However, given the complexity
of the limbal niche structure and its cellular components,
which cellular type has the main role in normal tissue
maintenance remains to be seen [16–18].
We previously identified a subpopulation of limbal stem
cells, which we referred to as fibroblast-like limbal stem
cells (f-LSCs) [19]. We indicated a core set of attributes that
uniquely characterize f-LSCs and that classify them as mes-
enchymal stem cells. In support of this, f-LSCs expressed
stem cell surface antigens SSEA4 (stage-specific embryonic
antigen-4), TRA 1–60, and TRA 1–81 and several nuclear
transcription factors, such as OCT4 (octamer-binding tran-
scription factor 4), NANOG (Homeobox protein NANOG),
and SOX2 (SRY (sex determining region Y)-box 2), in-
volved in self-renewal and maintenance of pluripotency of
both embryonic and adult stem cells [20, 21]. The f-LSCs
were positive for the limbal stem cell marker ABCG2
(ATP-binding cassette sub-family G member 2) and were
negative for the LESC marker ΔNp63 (a splice variant of
p63) [22–26]. More recently it has been hypothesized that
age negatively affects stem cell number and potential, also
referring to the LESC population [27, 28].
The current study was undertaken to explore whether
ex-vivo expansion of f-LSCs could modify their stem mo-
lecular features. Our study aimed to increase knowledge
in the field of limbal mesenchymal stem cell research
regarding three facets: firstly, we aimed to discover
whether long-term culture affects the gene expression and
proteomic profile of f-LSCs; secondly, we proposed a
preserved “proteomic stem cell pattern” in ageing and
long-term culture conditions; and finally, we evaluated
the maintenance of multilineage differentiation capability
in vitro.
Methods
Establishment of limbal cell cultures
Human tissues were used in accordance with the
Declaration of Helsinki and informed written consent
was given by each patient. The study was approved
by the Ethical Committee of the AOUP, University of
Palermo (No. 09/2009).
Normal human corneo-scleral rings from donors
aged between 24 and 74 years were obtained 2–3
hours post surgery in the Ophthalmology Department
(AOUP, University of Palermo, Italy). The rings were
kept in Hank’s Balanced Salt Solution (HBSS; PAA,
Pashing, Austria) and then cut into small segments to
facilitate isolation of the limbus from the sclera.
Enzymatic digestion and culture
The limbal segments were incubated with collagenase I
(5 mg/ml; Sigma-Aldrich, St. Louis, MO, USA) overnight
at 37 °C in a shaking bath. The following day, the digest
was placed in a p60 dish culture (Corning, New York,
USA) with the fibroblastic-maintenance medium (DMEM/
F12 supplemented with 10 % embryonic stem cell-tested
fetal bovine serum (EC-FBS; PAA), 1× ITS (5 μg/ml in-
sulin, 5 μg/ml transferrin, 5 μg/ml selenium; PAA), and
20 ng/ml basic fibroblast growth factor (b-FGF; Preprotech,
London, UK)) until cells reached confluence, changing the
medium when necessary.
Subsequently, the f-LSC subculture was kept in the ex-
pansion medium (f-EM: DMEM/F12 supplemented with
5 % EC-FBS (PAA), 1× ITS (PAA), and 4 ng/ml b-FGF
(Preprotech)).
Doubling time
The f-LSCs were subcultured and seeded at a density of
4 × 103 cells/cm2 and cell counts were performed at 24, 48,
72, 96, and 120 hours by optical microscope observation
after staining with vital trypan blue. The doubling time was
calculated online (http://www.doubling-time.com/compu
te.php; Roth V. 2006). For each sample of donor limbus,
three sets of experiments were used for calculations.
Sphere-forming assay
The f-LSCs were placed in ultralow-attachment six-well
plates (Corning) at a density of no more than 1 × 102
cells/cm2, and were cultured in f-EM without serum.
Sphere formation was assessed by counting the number
of spheres (cells > 3) under an optical microscope.
Immunofluorescence staining
The spheres were transferred into a cell-culture chamber
slide (Labtek II; Nunc, Waltham, MA, USA) and incubated
in f-EM, under adhesion-condition culture at 37 °C in 5 %
CO2 to allow their attachment. After 2 hours, cells were
washed with phosphate-buffered saline (PBS) and fixed for
30 minutes in 2 % (wt/vol.) paraformaldehyde in PBS at
room temperature, then incubated with 1 μg/ml PE-
conjugated anti-human SSEA-4 monoclonal antibody
(Miltenyi Biotec, Bergisch Gladbach, Germany) in PBS/
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bovine serum albumin (BSA; PAA) for 30 minutes, at room
temperature. After incubation the cells were washed three
times with PBS, counterstained with DAPI (Sigma Aldrich),
and observed under a Zeiss Axiophot fluorescence micro-
scope equipped with a Nikon DS-FI1 CCD camera.
Human bone marrow-derived MSCs (BM-MSCs; Lonza,
Walkersville, MD, USA) were used as a stem marker posi-
tive control, HeLa (kindly obtained from Dr Salvatore Feo
at University of Palermo) were used as an LESC marker
positive control, and unstained f-LSCs were used as a
negative control.
Sorting assay through magnetic isolation
The f-LSCs were magnetically separated for SSEA4 expres-
sion by MACS MicroBead Technology (Miltenyi Biotec)
according to the manufacturer’s instructions.
Flow cytometry analysis
The cells were harvested and filtered through a 40-μm fil-
ter mesh and suspended at a concentration of 1 × 106
cells/ml. Then 100 μl of cell suspension containing 5 × 105
cells was used for each flow cytometric test.
Immunophenotyping
Human anti-HLA-DR, human anti-CD34, and human anti-
CD45 monoclonal antibodies were tested on f-LSCs and
were detected with the appropriate secondary antibody
(Table 1). The incubation conditions were in accordance
with the manufacturers’ instructions.
Stem cell phenotypes
The cells were double-stained with human anti-SSEA4 and
human anti-ABCG2 monoclonal antibody, both surface
MSC markers. The f-LSCs were tested for SSEA4 and for
the human nuclear markers ΔNp63 or OCT4 or NANOG
monoclonal antibody, after permeabilization with PBS sup-
plemented with 0.1 % saponin and 1 % BSA for 20 minutes.
The antibody dilution, incubation, and detection con-
ditions are presented in Table 1.
All reaction mixtures were then acquired with a FACS
Calibur flow cytometer (Becton-Dickinson, Franklin
Lakes, NJ, USA) and analyzed with the CellQuest Pro
software. BM-MSCs were used as a positive control for
SSEA4, NANOG, ABCG2, and OCT4, and HeLa cells
were used as a positive control for ΔNp63.
Analysis of cell cycle status of MSCs
Single cell suspensions of f-LSCs were obtained from two
different culture passages: P4 and P30. For DNA content
analysis, Nicoletti’s protocol was performed. Briefly, 1 × 106
cells were fixed in 70 % ethanol, rehydrated in PBS, and
then resuspended in a DNA extraction buffer (with 0.2 M
NaHPO4, 0.1 % Tritonx-100, pH 7.8). After staining with
1 μg/ml of propidium iodide (PI) for 5 minutes, the fluores-
cence intensity was determined by analysis on a FACS Cali-
bur flow cytometer (Becton-Dickinson). Data acquisition
was performed with CellQuest software (Becton Dickinson),
and the percentages of phase G1, S, and G2 cells were
calculated with the MODFIT-LT software program (Verity
Software House, Inc. Augusta, Topsham, ME, USA).
RNA extraction, quantification, and retrotranscription
Total RNA was extracted and purified using E.Z.N.A. Total
RNA Kit I (Omega Bio-Tek Inc., Norcross, GA, USA)
according to the manufacturer’s instructions. RNA quantity
and quality were assessed by Nano Drop 2000 (Thermo
Scientific, Waltham, MA, USA), and 2 μg of f-LSC total
RNA was reverse-transcribed to cDNA in a volume of 20 μl
Table 1 Monoclonal antibodies used for the characterization of stem cell markers and cell phenotypes
Primary antibody/localization marker Code number Dilution Incubation
HLA-DR, surface Santa Cruz, sc-18875 1:50 o/n, r.t.
CD34, surface Santa Cruz, sc-19621 1:50 o/n, r.t.
CD45, surface Santa Cruz, sc-28369 1:50 o/n, r.t.
SSEA4, surface Miltenyi Biotec, 130-98-371 1:100 30 minutes, r.t.
ABCG2, surface BioLegend, 332002 1:100 o/n, r.t.
Δnp63, nuclear BioLegend, 619002 1:100 o/n, r.t.
NANOG, surface Santa Cruz, sc-293121 1:50 o/n, r.t.
OCT4, nuclear Santa Cruz, sc-5279 1:50 o/n, r.t.
Secondary antibody Code number Dilution Incubation
AlexaFluor 488 Life Technologies, Z25402 1:50 20 minutes, r.t.
AlexaFluor 594 Life Technologies, Z25007 1:50 20 minutes, r.t.
Miltenyi Biotec, Bergisch Gladbach, Germany
Santa Cruz, Dallas, Texas
BioLegend, London, UK
Life Technologies, Carlsbad, CA, USA
o/n overnight, r.t. room temperature
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with Oligo dT primers (Applied Biosystems, Carlsbad,
CA, USA) and the Reverse Transcriptase Rnase kit
(Improm II; Promega, Madison, WI, USA).
Real-time quantitative PCR
Real-time quantitative PCR primers were purchased from
Qiagen (QuantiTect® Primer Assays; Qiagen, Milan, Italy)
and Eurofin MWG (Biotech, Bergish Gladbach, Germany)
and are listed in Table 2. All reactions were performed using
the Quantitect SYBR Green PCR Kit (Qiagen, Valencia, CA,
USA) on the RotorGene Q Instrument (Qiagen, Valencia,
CA, USA). Each cDNA sample was mixed with specific
primer sets and PCR master mix. The PCR parameters
included denaturation at 95 °C for 3 minutes, then 40 cycles
at 95 °C for 20 seconds, annealing at 60 °C for 30 seconds,
and elongation at 72 °C for 60 seconds. Reactions were per-
formed at least in triplicate. The specificity of the amplified
products was determined by the melting peak analysis. The
relative quantification model with efficiency correction was
applied to normalize the expression of the target gene to
β-actin (used as the housekeeping gene) and to compare
gene expression with BM-MSCs (used as a positive cell
control), on Rest2009 software (Relative Expression Soft-
ware Tool; Qiagen, Valencia, CA, USA) [29]. The results
were represented as histograms on GraphPad software
(GraphPad Software, Inc., La Jolla, CA, USA).
Protein extraction
The f-LSCs were scraped and incubated on ice for
30 minutes with M-RIPA buffer (50 mM Tris, pH 7.5,
0.1 % Nonidet P-40, 0.1 % deoxycholate, 150 mM NaCl,
4 mM EDTA) and a mixture of protease inhibitors (0.01 %
aprotinin, 10 mM sodium pyrophosphate, 2 mM sodium
orthovanadate, 1 mM PMSF). The whole cellular lysate
was centrifuged at 12,000 rcf for 8 minutes to clear cell
debris and the supernatant was dialyzed against ultrapure
distilled water, lyophilized, and stored at –80 °C, as de-
scribed previously [30, 31]. The protein concentration in
the cellular extracts was determined using the Quick
Start™ Bradford Protein Assay (BIO RAD, Segrate, Milan,
Italy) according to the manufacturer’s instructions.
Proteomic analysis
Two-dimensional gel electrophoresis (2D-IPG) was per-
formed as described previously [30, 31]. Briefly, protein
samples of f-LSCs were solubilized, and aliquots of
45 μg (analytical gels) or 1.5 mg (preparative gels) of
total proteins were separately applied for isoelectrofo-
cusing (IEF) using commercial sigmoidal IPG strips,
18 cm long with pH range 3.0–10; BIO RAD). The
focused proteins were then separated on 9–16 % linear
gradient polyacrylamide gels (SDS-PAGE) and were visu-
alized by means of ammoniacal silver staining.
For image acquisition and data analysis, silver-stained
gels were digitized using a computing densitometer and
analyzed with ImageMaster 2D PLATINUM software
(Amersham, Little Chalfont, Buckinghamshire, UK). Gel
calibration was carried out using an internal standard
and the support of the ExPaSy molecular biology server;
the quantitative analysis of protein spots was performed
in duplicate maps, and normalized as vol. % (integration
of optical density over the spot area). The differential
expression of proteins was evaluated when the difference
in their values was ≥ 3 % volume. The labels correspond to
the access number of the Swiss-Prot/TrEMBL database.
Protein identification
Mass spectrometric sequencing was performed with
the Voyager DE-PRO (Applied Biosystems, Carlsbad,
CA USA) mass spectrometer [31]. Peptide mass fin-
gerprinting was compared with the theoretical masses
from the Swiss-Prot or NCBI sequence databases
using Mascot (http://www.matrixscience.com/).
Gene ontology and network analysis
The genes expressing the invariant and variant proteins
were analyzed for their enrichment in specific gene ontol-
ogy annotation using the Gene Ontology Consortium
website (http://geneontology.org/) (Additional file 1:
Table S2) [32].
Network analysis was performed on the genes ex-
pressing the invariant and variant proteins using the
STRING (Search Tool for the Retrieval of Interacting
Genes/Proteins) website (http://string-db.org/) [33].
Multilineage potential differentiation assays
Multilineage differentiation capability of f-LSCs at early
and late passages (P4 and P20) was assessed. The follow-
ing differentiation protocols were performed.
Osteogenesis
For osteogenic differentiation, 5 × 103/cm2 f-LSC cells
were cultured in home-made differentiation medium
consisting of DMEM supplemented with 15 % FBS, 10–4
mM dexamethasone (Sigma-Aldrich), 10 mM glycero-
phosphate (Sigma-Aldrich), and 0.05 mM ascorbic acid
Table 2 Real-time quantitative PCR primers used for gene
expression investigation
Gene Primer sequence Code number
CDKN1B QT00998445
ABCG2 QT00073206
NANOG QT01844808
OCT3/4 QT00210840
SOX2 F-GGAGACGGAGCTGAAGCCGC MWG
R-GACGCGGTCCGGGCTGTTTT
THY-1 QT00023569
Tomasello et al. Stem Cell Research & Therapy  (2016) 7:83 Page 4 of 14
(Sigma-Aldrich) [9]. After 21 days of culture in the dif-
ferentiation medium, cells were stained with Alizarin red
S (Sigma-Aldrich) to detect the calcium deposits. Briefly,
the medium was removed and the cells were fixed with
4 % formaldehyde solution for 30 minutes, and after fix-
ation were rinsed twice with distilled water and stained
with 2 % Alizarin red S (pH 4.2) for 3 minutes. After
incubation the cells were observed under a light optical
microscope at 20–40× magnification.
Adipogenesis
Adipose differentiation was induced by seeding 5 × 103/cm2
of f-LSCs and culturing in home-made differentiation
medium consisting of DMEM medium containing 10 %
FBS, 0.5 nM 1-methyl-3-isobutylxanthine (IBMX; Sigma-
Aldrich), 10–4 mM dexamethasone, 10 μg/ml insulin, and
100 μM indomethacin (Sigma-Aldrich) [34]. To detect the
presence of lipid droplets, cells were fixed with 4 % for-
maldehyde solution, rinsed twice in distilled water, stained
with Oil Red O (Sigma-Aldrich), and observed under a
light microscope at 20–40× magnification.
Chondrogenesis
Chondrogenic differentiation was induced by culturing
cell mass in serum-free DMEM (PAA) with 10 ng/ml
TGFβ-3 (Preprotech), 0.05 mM ascorbic acid (Sigma-
Aldrich), 2 mM sodium pyruvate (PAA), and 10–7
mM dexamethasone (Sigma-Aldrich) in a six-well cul-
ture plate. Briefly, micromass cultures were generated
by seeding 5-μl droplets of a cell solution of 1.6 × 107
viable cells/ml in f-EM. After 2 hours of incubation
at 37 °C, culture medium was replaced with chondrogene-
sis differentiation medium. After 21 days of culture the
cell mass was evaluated morphologically and stained
with Alcian blue to search for sulfated proteoglycan
deposits.
Statistical analysis
All assays were performed in triplicate. The data were
reported as means ± SD and compared using the appro-
priate version of Student’s unpaired t test. Test results
were reported as two-tailed p values, where p < 0.05 was
considered statistically significant.
Results
Isolation of f-LSCs
We determined that approximately 3 × 104–5 × 104 cul-
tured f-LSCs were isolated from each explanted human
corneo-scleral ring after enzymatic digestion. The digests
were kept in culture in f-EM (we referred to these culture
passages as P0) and in 2 weeks a single cell population
with an elongated shape was obtained (Fig. 1A.a).
Within 10 days the cells, kept in a low-adhesion
culture condition, gave rise to floating spherical cell
bodies (considered a hallmark of the stemness feature)
with a clear and well-delineated border, which we re-
ferred to as “limbospheres” (Fig. 1A.b). When trans-
ferred to adhesion conditions the limbospheres spread
out and a monolayer culture of fibroblast-like cells
formed (Fig. 1A.c,d).
SSEA4 expression was investigated by immunofluores-
cence analysis both in f-LSC spheres (Fig. 1B.a–c) and in
monolayer f-LSCs (Fig. 1B.f–h). BM-MSCs and HeLa cells
were respectively used as positive control (Fig. 1B.d–i) and
negative control (Fig. 1B.e–l). As reported in the literature,
it did not seem possible to obtain spheres from cells that
have no SSEA4 expression.
Flow cytometry demonstrated that SSEA4 was highly
expressed (88.95 ± 7.8 %) in f-LSC monolayer cultures
and did not significantly increase after sorting (90.76 ±
5.6 %). Immunophenotypes were analyzed in the pre-
sorting (total) population and the postsorting SSEA4+
population. Both populations showed almost no expres-
sion of CD34 (0.32 ± 0.01 % vs. 0.19 ± 0.02 %, respectively),
CD45 (1.35 ± 0.7 % vs. 0.65 ± 0.2 %, respectively), and
HLA-DR (0.25 ± 0.04 % vs. 0.16 ± 0.07 %, respectively)
(Fig. 1C).
Since neither population displayed any significant
differences in marker expression, the subsequent cell
analyses were only performed on the total monolayer
f-LSC population.
Proliferation in long-term culture
The distribution of f-LSCs in the various stages of the
cell cycle was investigated at two different passages. The
early passage P4 showed an increase in the percentage of
cells arrested in the G1 phase compared with the late-
passage P30 (76.15 ± 2.45 % vs. 89.90 ± 3.65 %, p < 0.05)
and a decrease in the percentage of cells in the S phase
and in the G2 phase (Fig. 2a, upper panel). Moreover, in
P30 the mRNA level of CDKN1B (cyclin-dependent kin-
ase inhibitor 1B, also known as P37) was increased up to
4.59-fold relative to P3 (Fig. 2a, left-lower panel). The
culture doubling time was slightly extended in P30 with
respect to P3 f-LSCs, reaching about 46.2 ± 5.37 hours
vs. 39.6 ± 2.54 hours (Fig. 2a, right-lower panel).
Flow cytometry stem cell phenotype characterization in
long-term culture
Phenotype characterization was performed at two different
culture passages (P3 and P30). A collection of double-
positive populations (dpp) was obtained for several
stem markers. The data expressions detected with flow
cytometry analysis are the following (P3 vs. P30):
ABCG2+/SSEA4+ = 98.6 ± 7.1 % vs. 96.6 ± 4.7 % (p =
NS); OCT4+/SSEA4+ = 92.1 ± 6.4 % vs. 88.3 ± 2.6 % (p =
NS); and NANOG+/SSEA4+ = 95.42 ± 6.8 % vs. 80.52 ±
4.2 % (p = NS). The f-LSCs did not express Δnp63
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Fig. 1 A: a Limbus digested after 2-week plate seeding: f-LSC growth in monolayer (P0 culture passage, 10×); b example of an f-LSC limbosphere
in low-adhesion culture conditions (20×); c, d example of an f-LSC limbosphere under adhesion culture condition (c 20×; d 40×). B: SSEA4+
immunofluorescence staining: a DAPI on a limbosphere; b SSEA4 detection on a limbosphere (20×); f DAPI on monolayer; g SSEA4 detection
in f-LSC monolayer (40×); c, h merge; d, i DAPI/SSEA4-stained BM-MSCs; e, l DAPI/SSEA4-stained HeLa cells. C: Cytofluorimetric assay in total
population (presorting, upper panel) and in SSEA4+ f-LSCs (postsorting, lower panel). Cells are negative for CD34, CD45, and HLA-DR. All fields
are representative of one limbus sample out of at least 12 independent experiments. DAPI 4′,6-diamidino-2-phenylindole, N.C. negative control,
P.C. positive control
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Fig. 2 (See legend on next page.)
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(Δnp63+/SSEA4+ < 0.5 %). Figure 2b shows one represen-
tative experiment out of a total of 25 sets of experiments.
The positive controls are shown in Additional file 2:
Figure S1.
Stem-related gene expression is not influenced by age
and by long-term cultures
We compared the f-LSC stem molecular expression
pattern in young donors (age < 45 years: N = 11, six
males and five females; Group A) and older donors
(age > 45 years: N = 14, eight males and six females;
Group B). No substantial differences were found in
the immune phenotype (Fig. 3a): both Groups A and
B were negative for CD34 (0.21 ± 0.07 % vs. 0.19 ±
0.1 %, p = NS), CD45 (0.27 ± 0.1 % vs. 0.13 ± 0.08 %,
p = NS), and HLA-DR (0.23 ± 0.12 % vs. 0.16 ± 0.04 %,
p = NS) whereas they highly expressed SSEA4 (92.3 ±
5.1 % vs. 90.76 ± 4.61 %, p = NS). The expression ana-
lysis performed on three different culture passages
(P3, P20, and P30) showed no substantial difference
(See figure on previous page.)
Fig. 2 a (Upper panel) Cell cycle distribution of f-LSCs (P4 on the left; P30 on the right) performed according to Nicoletti’s protocol. (Lower panel)
Increment of expression of CDKN1B in P30 vs. P4 (left); kinetics of f-LSCs at early passage (P4) and late passage (P30) in expansion medium (right).
Mean values ± SD of a set of 25 experiments after 6 days. b Cytometric detection of double-positive cell populations for pluripotent stem cell
markers at two different culture passages: early passage (P4) and late passage (P30). P passage
Fig. 3 Donor age and long-term culture effect on stem cell profile. a f-LSCs maintain negativity for CD34, CD45, and HLA-DR and are highly positive for
SSEA4 in patients < 45 years old (upper graph) and > 45 years old (lower graph). b Real-time quantitative PCR analysis of pluripotent stem cell markers in
f-LSC different culture passage obtained from patients of different ages. Mean values ± SD of all limbus donors studied are reported. P passage
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for all stem cell markers tested between f-LSCs of
patients within the two different groups (Figs. 3b,c).
Comparing the gene expression levels of the two groups,
it was clear that there was no significant age-related differ-
ence. The f-LSC stem cell markers, NANOG, THY-1, and
SOX-2, were firmly maintained, as well as ABCG2, thus
confirming maintenance of the limbal nature. Only OCT4
relative expression showed a faint decrease that appeared
to be correlated with long-term culture but not with age.
Moreover, CK12 (cytokeratin 12, corneal epithelial
marker) and ΔNp63 (LESC marker) were not expressed
(or only weakly expressed; data not shown), thus confirm-
ing that the culture conditions were not suitable for epi-
thelial differentiation. Our findings showed that cultured
and expanded f-LSCs exhibited similar expression pat-
terns both in long-term culture and soon after isolation,
maintaining their own expression characteristics.
The f-LSC proteomic profile is not influenced by age and
by long-term cultures
To further characterize the f-LSC phenotype, we performed
a proteomic analysis. Two-dimensional gel electrophoresis
assay resulted in a master gel that revealed 164 spots, 78 %
of which had an average pixel density of about 0.3 (Fig. 4a).
The list of assigned proteins is shown in Additional file 3:
Table S1. The derived protein f-LSC profiles represented by
the densitometry, expressed as a graph, are shown in Fig. 4b,
which also shows the relative intensities of the single pro-
tein expression levels. In Additional file 4: Figure S2, panels
A and B show the proteomic maps of f-LSCs from the same
older donor (Group B) at two different culture passages (P4
vs. P20), panels C and D show the proteomic maps of f-
LSCs from two different young donors of the same age
(Group A) at the same passage culture, and panel E
shows the proteomic map of P20 f-LSCs from one 64-
year-old donor (Group B). By comparing the f-LSC P4/
B and f-LSC P20/B proteomic profiles, we detected
overlapping for about 90 % of the proteins expressed
(Additional file 5: Figure S3A); to test the occurrence of
possible individual variants we compared the proteomic
profile of f-LSCs from different donors of the same age
(Group A) and we found overlapping for about 83 % of the
proteins (Additional file 5: Figure S3B). Moreover, compar-
ing the proteomic profiles of Group A with Group B donor
at the same culture passage, the proteomic profiles over-
lapped by about 68 % (Additional file 5: Figure S3C).
By comparative analysis between the proteomic profiles
of all investigated conditions, a protein group with higher
expression levels was detected. Eighty of the proteins main-
tained invariant expression levels, whereas 84 proteins
proved to be differentially expressed (Additional file 1:
Table S2). The Gene Ontology analysis showed that they
were related to cell growth/maintenance and apoptosis, en-
ergy pathways and signal transduction, membrane protein
metabolism, protein biosynthesis, folding and degradation,
cytoskeleton, and motility (Additional file 6: Table S3
and S4). Both in the invariant protein group and the
differential protein group the “catalytic activity” was the
most abundant class (33.3 % vs. 52.9 %, respectively).
The “structural molecule activity” was also well repre-
sented (21.6 % vs.13.7 %, unvaried vs. differential pro-
teins) (Fig. 5a,b) [34–46].
The protein-interaction networks (PIN) for the unvaried
protein groups revealed strong interactions between struc-
tural proteins (Fascin-1, cytoskeletal keratin 19), chaperones,
including two heat shock proteins (HSP70, HSP90), DNA
binding protein (i.e., elongation factors EEF1A, EEF1B2)
and remodeling and proteosome complex (PSMA5,4,6).
This profile is consistent with a stem phenotype that
requires plasticity and good proliferative ability [47, 48].
Interestingly, the hypoxia-inducible factor-1 (HIF-1)
pathway is a central node of differential protein group PIN
with close correlation between superoxide dismutase 2
(SOD2), thioredoxin (TXN), peroxiredoxin 6 (PRDX6),
and catepsin D (CTSD). It has been shown that HIF-1 is
involved in self-renewal and maintenance of pluripotency,
by promoting the expression of the putative stemness
genes (OCT4, SOX2, NANOG, Klf4) [49–51].
Multilineage capability of f-LSCs
We tested the differentiation capability of f-LSCs at an early
passage (P3) and a late passage (P10). Both were differenti-
ated in vitro using osteoblastic, adipose, and chondrogenic
home-made media, as described in Methods. Twenty-one
days after osteoblastic induction, Alizarin red S revealed the
presence of extracellular matrix mineralization in both f-
LSC cultures suggesting osteoblastic differentiation (Fig. 6a).
lcian blue positivity confirmed the presence of acid polysac-
charides (such as glycosaminoglycans) suggesting chondro-
genic differentiation 21 days after induction (Fig. 6b).
Moreover, oil red positivity confirmed the presence of
neutral triglyceride and lipid vacuoles, suggesting adipo-
genic differentiation after 28 days of culture (Fig. 6c).
Discussion
Ease of access and immune-privileged status make the
eye an ideal organ for its potential application in regen-
erative medicine. In our study, we confirmed the ease of
isolation of the subpopulation of f-LSCs, which make
them ideal candidates for adult stem cell therapy. In
spite of the great interest in clinical applications, no ex-
haustive information is yet available on f-LSCs, espe-
cially on their exact characteristics. The International
Society for Cellular Therapy has defined criteria to iden-
tify MSCs [52]. We adopted these criteria to characterize
f-LSCs from the limbus in our study. In addition, this
work provides convincing evidence that limbal stroma
contains f-LSCs. The latter subpopulation resembles
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Fig. 4 a f-LSC two-dimensional electrophoresis master proteomic map with labeled proteins. Two-dimensional gel electrophoresis assay resulted
in a master gel that revealed 164 spots, 78 % of which had an average pixel density of about 0.3. b Densitometry profile of f-LSC proteins. f-LSC
fibroblast-like limbal stem cell
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Fig. 5 Pie charts representing the GO molecular function of unvaried proteins a and differential expressed proteins b. Protein network of f-LSC unvaried
proteins c and differential expressed proteins, performed on the STRING website d. Protein class distribution of unvaried e and differential expressed
proteins f, performed on the Gene Ontology website
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stem cells which reside in the stem cell niche, where
they are maintained in an undifferentiated state. These
observations were supported by Notara and Daniels
[53] who showed that LESCs are discretely located in
the basal layer of the corneal limbal epithelium, at the
junction between the transparent cornea and the
opaque sclera. The limbal palisades of Vogt have been
proposed as the site of the LESC niche whereas f-LSCs
seem to reside in the extracellular matrix [3, 4]. Corneal
stromal stem cells have been located in the anterior
stroma subadjacent to the basal side of the palisades of
Vogt [54–60]. In our study we did not aim to define the
exact localization of f-LSCs but confirmed that they are
completely different from LESCs, as demonstrated by
ΔNp63 and CK12 and CK19 negativity, and they can be
easily isolated and grown.
In our research we showed that f-LSCs fulfilled the
criteria for multipotency established today.
In particular, our group investigated the possible ef-
fects of long-term culture conditions and donor age on
the f-LSC phenotype. The cells isolated did not display
surface expression of any hematopoietic marker (CD34
and CD45) and HLA-DR. By contrast, they expressed a
variety of stemness markers (SSEA4, ABCG2, OCT3/4,
and NANOG).
They showed low adhesion growth capability as limbo-
spheres and they should proliferate in vitro as adherent
cells for long-term culture, maintaining positivity for
ABCG2, OCT3/4, NANOG, SOX2, THY-1, and SSEA4
and negativity for CD34, CD45, and HLD-DR; and they
have multilineage differentiation potential under in-vitro
culture conditions. By comparing the cell cycle distribu-
tion and the proliferation curve in the early and late pas-
sages there was a weak increase in the percentage of
cells in phase G1 with a concomitant decrease in the
percentage of cells in phase S. This event is reflected as
a slight elongation in the doubling time in late passage
culture but was not analyzed in more detail.
The evaluation of molecular expression of f-LSCs iso-
lated from different donors (with the same or different age)
and at different culture passages revealed a strong stability
of the “limbal stem molecular pattern”, not affected by
long-term culture and donor age. No significant differences
were found regarding specific osteogenic, adipogenic, or
chondrogenic staining.
For the first time, we constructed a two-dimensional
electrophoresis (2-DE) proteomic pattern of cultured f-
LSCs. The derived pattern of resolved protein spots was
highly consistent; we identified 164 proteins stably
expressed in the different conditions, defining profiles
enriched in proteins linked to cell plasticity and prolifera-
tive and self-renewal capability. Furthermore, overlapping
protein expression profiles confirm the stability of the
stem cell phenotype with higher expression of structural
proteins and proteins involved in the stem molecular
pathway.
Conclusions
f-LSCs represent a robust source of MSCs independently
of donor age and in-vitro conditions; the stability of their
proteomic pattern could be very promising, suggesting
their potential use in regenerative medicine.
Additional files
Additional file 1: Table S2 Catalogue of the unvaried and differential
expressed proteins in f-LSCs samples. (ZIP 110 kb)
Additional file 2: Figure S1 Positive Control of cytofluorimetric assay:
Human bone marrow mesechymal stem cells (BM-MSCs) stained positive
for SSEA4 (A), ABCG2 (B), OCT4 ( C ) and NANOG (D); HeLa cells stained
positive for ΔNp63 (E). A cell suspension of BM-MSCs and HeLa was
obtained by trypsinization and centrigugation. The cell pellet was
resuspended in 100μl of PBS to test SSEA4 or ABCG2. The samples were
resuspended in PBS supplemented with 0.1% saponin and 1% BSA for 20
minutes for permeabilization cells and finally stained for OCT4 or NANOG or
ΔNp63. (TIF 686 kb)
Additional file 3: Table S1 Catalogue of the protein spots identified in
the 2D-IPG prototype map of f-LSCs. Table reports the following
information: Protein names, accession numbers (AC) and abbreviated
names correspond to the nomenclature used in the Swiss-Prot database.
The experimental values of pI and MW for every isoelectric spot were
calculated with ImageMaster 2D Platinum system; the theoretical values
represent the predicted MW and pI for each identified protein according
Fig. 6 a f-LSCs stained with Alizarin red S for detection of calcific deposition in cultured f-LSCs for differentiation towards an osteogenic lineage.
b Alcian blue staining to detect chondrogenic differentiation. c Oil Red O-stained neutral triglycerides and lipids on adipose-differentiated cells.
The appropriate medium for the multilineage differentiation is reported in Methods
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to Swiss-Prot and TrEMBL database. Identification methods: 1, MALDI-TOF;
2, N-terminal sequencing by automated Edman degradation and 3,
Western Blotting. (DOC 198 kb)
Additional file 4: A) The proteomic map of P4 f-LSCs from >45 years
donor; B) The proteomic map of P20 f-LSCs from >45 years donor f-LSCs; C,
D) The proteomic maps of P10 f-LSCs from 2 donors < 45 years; E) The
proteomic map of P20 f-LSCs from one 64 years old donor. (TIF 2807 kb)
Additional file 5: Figure S3 Figure.5: A) Proteomic profile analysis of P4
f-LSCs>45 years vs. f-LSC P20 f-LSCs >45 years, overlapped for about 90%
of proteins expressed; B) f-LSCs from 2 different donors of the same age
(<45 years) overlapped for about 83% of proteins; C) proteomic profiles of
the same cutlure passage f-LSCs from 2 donors of different ages (< 45 years
vs. >45 years) overlapped for about 68%. P= passage. (TIF 25509 kb)
Additional file 6: Table S3. The genes expressing the invariant proteins
were analyzed for their enrichment in specific gene ontology annotation.
Table S4. The genes expressing the differenzial proteins were analyzed for
their enrichment in specific gene ontology annotation. (XLS 16 kb)
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